Peptide Technologies vs Polaris Peptides
Independent side-by-side comparison across the 2 peptides both vendors sell. Composite scores, lab quality, and verified pricing.
Peptide Technologies
5 BPC-157 tests with score variance 5.0–10.0. GHK-Cu and Ipamorelin coverage solid.
Peptide Technologies full review →Polaris Peptides
9 peptides with 97 lab tests. Tirzepatide and PT-141 grade A; Retatrutide drops to D due to wider score variance.
Polaris Peptides full review →Side-by-side breakdown
| PEPTIDE | PEPTIDE TECHNOLOGIES | POLARIS PEPTIDES | WINNER |
|---|---|---|---|
| GHK-Cu |
7.4
B (6 tests)
|
8.8
B+ (8 tests)
|
Polaris Peptides |
| BPC-157 |
6.5
B (5 tests)
|
5.4
C (11 tests)
|
Peptide Technologies |
| Tirzepatide |
—(not sold)
|
8.8
B+ (15 tests)
|
Polaris Peptides only |
| Ipamorelin |
—(not sold)
|
8.0
B+ (5 tests)
|
Polaris Peptides only |
| Retatrutide |
—(not sold)
|
7.3
B (26 tests)
|
Polaris Peptides only |
| Semaglutide |
—(not sold)
|
6.9
B (16 tests)
|
Polaris Peptides only |
Which to choose
Across the 2 peptides both vendors sell, Peptide Technologies scores higher on 1, Polaris Peptides scores higher on 1, and 0 are within 0.3 points (effectively tied). Polaris Peptides additionally sells Tirzepatide, Ipamorelin, Retatrutide, Semaglutide; Peptide Technologies does not.
Choose Peptide Technologies for: BPC-157.
Choose Polaris Peptides for: GHK-Cu.
Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.
Full profiles: Peptide Technologies review · Polaris Peptides review